arsenic has been researched along with Prostatic Neoplasms in 54 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (3.70) | 18.7374 |
1990's | 1 (1.85) | 18.2507 |
2000's | 14 (25.93) | 29.6817 |
2010's | 28 (51.85) | 24.3611 |
2020's | 9 (16.67) | 2.80 |
Authors | Studies |
---|---|
Budillon, A; Ciliberto, G; Costantini, S; De Petro, G; Marchese, S; Montella, M; Polo, A | 1 |
Jiang, T; Li, QL; Peng, JQ; Su, XM; Sun, DC; Zhang, ZW; Zheng, L | 1 |
Doi, H; Knox, SJ; Li, X; Peehl, DM; Saar, M; Santos, J; Tian, J | 1 |
Ji, H; Jiang, F; Li, Y; Shen, J; Wang, X; Yang, X; Zhang, J | 1 |
Bansal, N; Bertino, JR; Farley, NJ; Lewis, J; Wu, L; Youssoufian, H | 1 |
Bhatt, P; Jadhav, V; Ray, P; Sachdeva, G | 1 |
Cao, H; Chen, L; Feng, Y | 1 |
Liang, C; Tai, S; Xu, L; Xu, M; Zhang, K; Zhang, L; Zhang, Y | 1 |
Burnstein, KL; Rosenblatt, AE | 1 |
Chen, L; Dong, Z; Meng, Q; Peng, Z; Si, J; Xia, Y | 1 |
Chen, YA; Chiu, HW; Ho, SY; Wang, YJ | 1 |
Alhasan, MK; Lewis, MA; Liu, L; Magnusson, J; Mason, RP | 1 |
DANBOLT, N; FOSS, MH | 1 |
Cohen, FJ; Gui, D; Ikezoe, T; Koeffler, HP; Kumagai, T; O'Kelly, J; Said, JW; Tong, XJ | 1 |
Hori, S; Kakehi, Y; Kakizuka, A; Maeda, H; Ogawa, O; Ohizumi, H; Segawa, T | 1 |
Jing, Y; Lu, M; Luo, D; Waxman, S; Xia, L | 1 |
Jiang, H; Jiang, T; Wang, Y | 1 |
Goker, E; Karabulut, B; Omay, SB; Sanli, UA; Sezgin, C; Terzioglu, E; Uslu, R | 1 |
Hori, S; Ichijo, H; Kakehi, Y; Kakizuka, A; Maeda, H; Nishitoh, H; Ogawa, O | 1 |
Lees, RE; Steele, R; Wardle, D | 1 |
He, Q; Ke, Z; Liang, C; Lin, R; Liu, H; Meng, J; Miao, Z; Wang, H; Wen, L; Zha, Z; Zhang, L; Zhang, M | 1 |
Gernand, J; Geyer, NR; McDonald, AC; Wang, M; Wu, H; Yang, Y | 1 |
McDonald, AC; Pan, Y; Wang, M; Wang, X; Yang, Y | 1 |
Bosland, MC; Horton, L | 1 |
Abidi, SSR; Keltie, E; Kim, JS; Majouni, S; Sweeney, E | 1 |
Adisesh, A; Bharti, V; Cui, Y; Dummer, T; Hood, KM; Ilie, G; Keltie, E; Kim, JS; Sweeney, E | 1 |
Boffetta, P; Cohen, SM; Collatuzzo, G | 1 |
Ahmadi, Z; Baghery, F; Eslami, H; Javedani, H; Lau, LDW; Mohamadi, M; Nazari, A; Vazirinejad, R | 1 |
Ankem, MK; Chandrasekaran, B; Damodaran, C; Fu, H; Juneau, AD; Saran, U; Shukla, V; Talluri, S; Tyagi, A; Tyagi, B; Tyagi, N | 1 |
Chia, SE; Geok, PP; Lee, J; Lim, JT; Ong, CN; Seow, WJ; Tan, YQ; Valeri, L | 1 |
Berindan-Neagoe, I; Gurzau, E; Manda, G; Schitcu, V; Stavaru, C; Szedlacsek, S; Zimta, AA | 1 |
Chen, WJ; Hsueh, YM; Huang, CY; Lin, YC; Pu, YS; Shiue, HS; Su, CT; Tsai, CS | 1 |
Kelly, KM; Ludewig, G; Lynch, CF; Roh, T; Wang, K; Weyer, P | 1 |
Aballay, LR; Díaz, MDP; Lantieri, MJ; Muñoz, SE; Niclis, C; Román, MD | 1 |
Chang, PL; Chung, LC; Feng, TH; Juang, HH; Lee, YH; Sung, HC; Tsui, KH | 1 |
Kale, RK; Prajapati, V; Singh, RP | 1 |
Figueiredo, ML; Lichti, CF; Nilsson, CL; Shearer, JJ; Umbaugh, CS; Wold, EA | 1 |
Makia, NL; Ngalame, NN; Tokar, EJ; Waalkes, MP | 1 |
Argos, M; Bulka, CM; Jones, RM; Stayner, LT; Turyk, ME | 1 |
Barrett, JR | 2 |
Kulawiec, M; Owens, KM; Singh, A; Singh, B; Singh, KK | 1 |
Díaz, Mdel P; Eynard, AR; La Vecchia, C; Niclis, C; Román, MD | 1 |
Chen, D; Cui, Q; Dou, QP; Kandegedara, A; Mitra, B; Neslund-Dudas, C; Rybicki, BA; Schmitt, S; Shen, M | 1 |
Sun, Y; Tokar, EJ; Waalkes, MP; Xu, Y | 1 |
Futscher, BW; Severson, PL; Tokar, EJ; Vrba, L; Waalkes, MP | 1 |
Benbrahim-Tallaa, L; Waalkes, MP; Webber, MM | 2 |
Garrett, SH; Gurel, V; Park, S; Sens, DA; Sens, MA; Somji, S; Zhou, XD | 1 |
Navarro Silvera, SA; Rohan, TE | 1 |
Benbrahim-Tallaa, L; Waalkes, MP | 1 |
Antich, PP; He, J; Hermanne, A; Jennewein, M; Kodibagkar, VD; Kulkarni, P; Lewis, MA; Mason, RP; O'Kelly, S; Rösch, F; Slavine, N; Thorpe, PE; Tsyganov, E; Watkins, L; Zhao, D | 1 |
Barter, RA; Coogan, TP; Waalkes, MP | 1 |
8 review(s) available for arsenic and Prostatic Neoplasms
Article | Year |
---|---|
Arsenic exposures and prostate cancer risk: A multilevel meta-analysis.
Topics: Arsenic; Humans; Male; Prospective Studies; Prostatic Neoplasms; Soil; Water | 2022 |
Re: Yang et al., Arsenic exposures and prostate cancer risk: A multilevel meta-analysis [J. Trace Elem. Med. Biol. (2022) 72 126992].
Topics: Arsenic; Humans; Male; Prostatic Neoplasms | 2023 |
Risk of urinary tract cancers following arsenic exposure and tobacco smoking: a review.
Topics: Arsenic; Environmental Exposure; Humans; Kidney Neoplasms; Male; Prostatic Neoplasms; Smoking; Tobacco Smoking; Urinary Bladder Neoplasms | 2023 |
Biological and molecular modifications induced by cadmium and arsenic during breast and prostate cancer development.
Topics: Arsenic; Breast Neoplasms; Cadmium; Cell Transformation, Neoplastic; Environmental Exposure; Environmental Pollutants; Humans; Male; Metals, Heavy; Prostatic Neoplasms | 2019 |
Dietary habits and prostate cancer prevention: a review of observational studies by focusing on South America.
Topics: Arsenic; Calcium; Carotenoids; Dairy Products; Eggs; Epidemiologic Studies; Feeding Behavior; Fruit; Humans; Lycopene; Male; Meat; Prostatic Neoplasms; Risk Factors; Selenium; Solanum lycopersicum; South America; Vegetables | 2012 |
Trace elements and cancer risk: a review of the epidemiologic evidence.
Topics: Arsenic; Breast Neoplasms; Cadmium; Environmental Exposure; Female; Humans; Lung Neoplasms; Male; Neoplasms; Prostatic Neoplasms; Risk Factors; Selenium; Trace Elements; Zinc | 2007 |
Inorganic arsenic and human prostate cancer.
Topics: Arsenic; Carcinogens; Environmental Exposure; Humans; Male; Prostatic Neoplasms | 2008 |
Toxicological principles of metal carcinogenesis with special emphasis on cadmium.
Topics: Animals; Arsenic; Cadmium; Chromium; Confounding Factors, Epidemiologic; DNA; Dose-Response Relationship, Drug; Drug Interactions; Environmental Exposure; Humans; Lung Diseases; Lung Neoplasms; Male; Metals; Mice; Mutagenesis; Neoplasms; Nickel; Occupational Exposure; Prostatic Neoplasms; Rats | 1992 |
46 other study(ies) available for arsenic and Prostatic Neoplasms
Article | Year |
---|---|
Identifying a panel of genes/proteins/miRNAs modulated by arsenicals in bladder, prostate, kidney cancers.
Topics: Arsenicals; beta Catenin; Cell Cycle Proteins; Disease-Free Survival; Drinking Water; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Humans; Intracellular Signaling Peptides and Proteins; Kidney Neoplasms; Male; MAP Kinase Kinase Kinases; MicroRNAs; Poly(A)-Binding Proteins; Prostatic Neoplasms; Receptors, Glucocorticoid; Retinoid X Receptor alpha; Transcription Factor RelA; Urinary Bladder Neoplasms | 2018 |
[Arsenic trioxide induces the apoptosis of prostate cancer PC-3 cells via the P38 signaling pathway].
Topics: Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Humans; Male; MAP Kinase Signaling System; Oxides; p38 Mitogen-Activated Protein Kinases; Prostatic Neoplasms; Signal Transduction | 2013 |
Radioprotection and cell cycle arrest of intestinal epithelial cells by darinaparsin, a tumor radiosensitizer.
Topics: Animals; Apoptosis; Arsenicals; Cell Cycle Checkpoints; DNA Damage; DNA Repair; Duodenum; Epithelial Cells; Female; Gastrointestinal Tract; Glutathione; Heterografts; Humans; Male; Mice; Prostatic Neoplasms; Radiation Injuries, Experimental; Radiation Tolerance; Radiation-Protective Agents; Radiation-Sensitizing Agents; Syndrome | 2013 |
Inhibition of transforming growth factor beta/SMAD signal by MiR-155 is involved in arsenic trioxide-induced anti-angiogenesis in prostate cancer.
Topics: Angiogenesis Inhibitors; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Human Umbilical Vein Endothelial Cells; Humans; Male; MicroRNAs; Oxides; Prostatic Neoplasms; Signal Transduction; Smad Proteins; Transforming Growth Factor beta | 2014 |
Darinaparsin inhibits prostate tumor-initiating cells and Du145 xenografts and is an inhibitor of hedgehog signaling.
Topics: Animals; Antineoplastic Agents; Arsenicals; Cell Cycle; Cell Line, Tumor; Docetaxel; Dose-Response Relationship, Drug; Drug Synergism; Gene Expression Regulation, Neoplastic; Glutathione; Hedgehog Proteins; Humans; Kruppel-Like Transcription Factors; Male; Mice; Neoplastic Stem Cells; Nuclear Proteins; Prostatic Neoplasms; Signal Transduction; Taxoids; Xenograft Model Antitumor Assays; Zinc Finger Protein Gli2 | 2015 |
Biocompatible arsenic trioxide nanoparticles induce cell cycle arrest by p21(WAF1/CIP1) expression via epigenetic remodeling in LNCaP and PC3 cell lines.
Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Biocompatible Materials; Cell Cycle Checkpoints; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Dose-Response Relationship, Drug; Epigenesis, Genetic; Humans; Male; Metal Nanoparticles; Oxides; Prostatic Neoplasms | 2016 |
Repression of MicroRNA-372 by Arsenic Sulphide Inhibits Prostate Cancer Cell Proliferation and Migration through Regulation of large tumour suppressor kinase 2.
Topics: Animals; Antineoplastic Agents; Arsenicals; Biomarkers, Tumor; Cell Line, Tumor; Cell Movement; Cell Proliferation; Down-Regulation; Humans; Male; Mice; Mice, Nude; MicroRNAs; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Sulfides; Tumor Suppressor Proteins; Up-Regulation; Xenograft Model Antitumor Assays | 2017 |
Combination of Arsenic trioxide and Everolimus (Rad001) synergistically induces both autophagy and apoptosis in prostate cancer cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Autophagy; Beclin-1; Cell Line, Tumor; Drug Synergism; Everolimus; Gene Expression Regulation, Neoplastic; Humans; Immunoblotting; Male; Mice, SCID; Microscopy, Fluorescence; Microtubule-Associated Proteins; Oxides; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Xenograft Model Antitumor Assays | 2017 |
Inhibition of androgen receptor transcriptional activity as a novel mechanism of action of arsenic.
Topics: Androgen Antagonists; Androgen Receptor Antagonists; Androgens; Anilides; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Cell Nucleus; Cell Proliferation; Drug Evaluation, Preclinical; Drug Synergism; Humans; Male; Nitriles; Nuclear Receptor Coactivator 2; Oxides; Prostatic Neoplasms; Protein Binding; Protein Structure, Tertiary; Protein Transport; Receptors, Androgen; Response Elements; Tosyl Compounds; Transcriptional Activation; Tumor Cells, Cultured | 2009 |
Arsenic and prostate cancer.
Topics: Arsenicals; Biomarkers; Cell Transformation, Neoplastic; Environmental Exposure; Erectile Dysfunction; Humans; Male; Prostate; Prostatic Neoplasms; United States; Water Pollution, Chemical; Water Supply | 2009 |
Nuclear Factor-κB modulates cellular glutathione and prevents oxidative stress in cancer cells.
Topics: Animals; Arsenic Trioxide; Arsenicals; Glutathione; Humans; Leukemia; Male; Mice; NF-kappa B; Oxidative Stress; Oxides; Prostatic Neoplasms; Signal Transduction | 2010 |
Arsenic trioxide enhances the radiation sensitivity of androgen-dependent and -independent human prostate cancer cells.
Topics: Androgens; Animals; Apoptosis; Arsenic Trioxide; Arsenicals; Autophagy; Body Weight; Cell Line, Tumor; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Therapy, Combination; Humans; Male; Mice; Mice, Nude; Oxides; Phosphatidylinositol 3-Kinases; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Radiation Tolerance; Radiation, Ionizing; Signal Transduction; Time Factors; Tumor Burden | 2012 |
Comparison of optical and power Doppler ultrasound imaging for non-invasive evaluation of arsenic trioxide as a vascular disrupting agent in tumors.
Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Blood Vessels; Brain Neoplasms; Breast Neoplasms; Cell Line, Tumor; Female; Humans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Optical Imaging; Oxides; Prostatic Neoplasms; Ultrasonography, Doppler | 2012 |
[Arsenical treatment as a cause of cancer of skin & internal organs].
Topics: Arsenicals; Bronchi; Humans; Male; Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms; Skin Neoplasms; Urinary Bladder Neoplasms | 1958 |
RWJ-241947 (MCC-555), a unique peroxisome proliferator-activated receptor-gamma ligand with antitumor activity against human prostate cancer in vitro and in beige/nude/ X-linked immunodeficient mice and enhancement of apoptosis in myeloma cells induced by
Topics: Agar; Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Blotting, Western; Caspases; CD36 Antigens; Cell Cycle; Cell Differentiation; Cell Division; Cell Line, Tumor; Cell Survival; Genetic Linkage; Humans; Immunologic Deficiency Syndromes; Ligands; Luciferases; Male; Mice; Multiple Myeloma; Oxides; Prostatic Neoplasms; Receptors, Cytoplasmic and Nuclear; Tetrazolium Salts; Thiazoles; Thiazolidinediones; Time Factors; Transcription Factors; Transfection; U937 Cells; X Chromosome | 2004 |
Effective treatment of advanced solid tumors by the combination of arsenic trioxide and L-buthionine-sulfoximine.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Buthionine Sulfoximine; Cell Division; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance, Neoplasm; Drug Therapy, Combination; Female; Glutathione; HeLa Cells; Humans; Hydrogen Peroxide; Male; Mice; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms; Oxides; Prostatic Neoplasms; Reactive Oxygen Species; Transplantation, Heterologous; Xenograft Model Antitumor Assays | 2004 |
Dual effects of glutathione-S-transferase pi on As2O3 action in prostate cancer cells: enhancement of growth inhibition and inhibition of apoptosis.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Glutathione S-Transferase pi; Glutathione Transferase; Humans; Isoenzymes; Male; Oxides; Prostatic Neoplasms | 2004 |
[Experimental research on the effect of arsenic trioxide on the growth of prostate cancer PC-3 cell lines].
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Humans; Male; Oxides; Prostatic Neoplasms | 2004 |
Arsenic trioxide-mediated cytotoxicity and apoptosis in prostate and ovarian carcinoma cell lines.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Arsenic Trioxide; Arsenicals; Butylated Hydroxyanisole; Carcinogens; Cisplatin; DNA Fragmentation; Dose-Response Relationship, Drug; Doxorubicin; Enzyme-Linked Immunosorbent Assay; Etoposide; Female; Flow Cytometry; Humans; Male; Ovarian Neoplasms; Oxides; Prostatic Neoplasms; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 2000 |
Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer.
Topics: Androgens; Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Caspases; Cell Death; Cell Division; Dose-Response Relationship, Drug; Enzyme Activation; Humans; JNK Mitogen-Activated Protein Kinases; Male; MAP Kinase Kinase 4; Mice; Mice, Inbred BALB C; Mice, SCID; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Neoplasm Metastasis; Neoplasm Transplantation; Neoplastic Stem Cells; Oxides; p38 Mitogen-Activated Protein Kinases; Prostatic Neoplasms; Reactive Oxygen Species; Transplantation, Heterologous; Tumor Cells, Cultured; Tumor Stem Cell Assay; Xenograft Model Antitumor Assays | 2001 |
Arsenic, syphilis, and cancer of the prostate.
Topics: Age Factors; Arsenicals; Humans; Male; Ontario; Prostatic Neoplasms; Syphilis | 1985 |
PSMA-targeted arsenic nanosheets: a platform for prostate cancer therapy via ferroptosis and ATM deficiency-triggered chemosensitization.
Topics: Arsenic; Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Ferroptosis; Glutathione; Humans; Male; Prostatic Neoplasms | 2021 |
Ambient air exposures to arsenic and cadmium and overall and prostate cancer-specific survival among prostate cancer cases in Pennsylvania, 2004 to 2014.
Topics: Arsenic; Cadmium; Humans; Male; Pennsylvania; Prostate; Prostatic Neoplasms | 2022 |
Sodium arsenite does not affect prostate carcinogenesis in a chemically-hormonally-induced rat model.
Topics: Animals; Arsenic; Arsenites; Carcinogenesis; Drinking Water; Humans; Male; Prostate; Prostatic Neoplasms; Rats; Sodium Compounds; Testosterone | 2022 |
Applying Machine Learning to Arsenic Species and Metallomics Profiles of Toenails to Evaluate Associations of Environmental Arsenic with Incident Cancer Cases.
Topics: Arsenic; Drinking Water; Environmental Exposure; Humans; Machine Learning; Male; Nails; Nova Scotia; Prostatic Neoplasms; Water Pollutants, Chemical | 2022 |
Arsenic Speciation and Metallomics Profiling of Human Toenails as a Biomarker to Assess Prostate Cancer Cases: Atlantic PATH Cohort Study.
Topics: Arsenic; Biomarkers; Cohort Studies; Humans; Male; Nails; Prostatic Neoplasms | 2022 |
Exposure of environmental trace elements in prostate cancer patients: A multiple metal analysis.
Topics: Arsenic; Cadmium; Environmental Monitoring; Humans; Lead; Male; Metals, Heavy; Prostatic Neoplasms; Trace Elements | 2023 |
Association between serum heavy metals and prostate cancer risk - A multiple metal analysis.
Topics: Aged; Arsenic; Bayes Theorem; Biological Monitoring; Humans; Male; Metals, Heavy; Middle Aged; Prostatic Neoplasms; Risk Factors; Selenium; Singapore | 2019 |
Levels of plasma selenium and urinary total arsenic interact to affect the risk for prostate cancer.
Topics: Aged; Arsenic; Case-Control Studies; Humans; Male; Prostatic Neoplasms; Selenium | 2017 |
Low-level arsenic exposure from drinking water is associated with prostate cancer in Iowa.
Topics: Adult; Aged; Aged, 80 and over; Arsenic; Drinking Water; Environmental Exposure; Humans; Incidence; Iowa; Male; Middle Aged; Prostatic Neoplasms; Risk Factors; Water Pollutants, Chemical | 2017 |
Do Exposure to Arsenic, Occupation and Diet Have Synergistic Effects on Prostate Cancer Risk?
Topics: Aged; Aged, 80 and over; Argentina; Arsenic; Case-Control Studies; Diet; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Occupational Exposure; Prognosis; Prostatic Neoplasms; Risk Factors | 2018 |
Metallothionein 3: an androgen-upregulated gene enhances cell invasion and tumorigenesis of prostate carcinoma cells.
Topics: Androgens; Animals; Arsenic; Cadmium; Carcinogenesis; Carcinoma; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Gene Expression Regulation, Neoplastic; Genetic Enhancement; Humans; Intracellular Signaling Peptides and Proteins; Male; Metallothionein; Metallothionein 3; Mice; Prostatic Neoplasms; Serpins; Signal Transduction; Up-Regulation | 2013 |
Silibinin combination with arsenic strongly inhibits survival and invasiveness of human prostate carcinoma cells.
Topics: Apoptosis; Arsenic; Autophagy; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinases; Cyclins; Humans; Male; Matrix Metalloproteinase 2; Neoplasm Invasiveness; Oxidative Stress; Prostatic Neoplasms; Reactive Oxygen Species; Silybin; Silymarin; Vimentin | 2015 |
Inorganic Arsenic-Related Changes in the Stromal Tumor Microenvironment in a Prostate Cancer Cell-Conditioned Media Model.
Topics: Arsenic; Cell Line, Tumor; Cell Proliferation; Hazardous Substances; Humans; Male; Mesenchymal Stem Cells; Prostatic Neoplasms; Tumor Microenvironment | 2016 |
Mitigation of arsenic-induced acquired cancer phenotype in prostate cancer stem cells by miR-143 restoration.
Topics: Arsenic; Carcinogens; Cell Line, Tumor; Humans; Lim Kinases; Male; Matrix Metalloproteinases; MicroRNAs; Neoplastic Stem Cells; Prostatic Neoplasms | 2016 |
Arsenic in drinking water and prostate cancer in Illinois counties: An ecologic study.
Topics: Adolescent; Adult; Aged; Arsenic; Carcinogens; Humans; Illinois; Incidence; Male; Middle Aged; Models, Statistical; Prostatic Neoplasms; Regression Analysis; Water Pollutants, Chemical; Young Adult | 2016 |
Stroma Insights: Potential Mechanism for Arsenic-Induced Prostate Cancer.
Topics: Arsenic; Cell Line, Tumor; Humans; Male; Prostatic Neoplasms; Stromal Cells | 2016 |
Sustained Early Disruption of Mitochondrial Function Contributes to Arsenic-Induced Prostate Tumorigenesis.
Topics: Animals; Arsenic; Cell Line, Tumor; Electron Transport Complex I; Heterografts; Humans; Male; Mice; Mice, SCID; Mitochondria; NADPH Oxidase 4; NADPH Oxidases; Neoplasm Transplantation; Oxidative Stress; Prostatic Neoplasms; Reactive Oxygen Species; Tumor Suppressor Protein p53 | 2016 |
Association of metals and proteasome activity in erythrocytes of prostate cancer patients and controls.
Topics: Adult; Aged; Arsenic; Cadmium; Case-Control Studies; Chymotrypsin; Copper; Environmental Exposure; Enzyme Activation; Erythrocytes; Gene-Environment Interaction; Humans; Lead; Male; Mass Spectrometry; Middle Aged; Multivariate Analysis; Prostatic Neoplasms; Proteasome Endopeptidase Complex | 2012 |
Arsenic-transformed malignant prostate epithelia can convert noncontiguous normal stem cells into an oncogenic phenotype.
Topics: Arsenic; Blotting, Western; Cell Line, Tumor; Cell Transformation, Neoplastic; Epithelial Cells; Fluorescent Antibody Technique; Gene Expression Regulation, Neoplastic; Humans; Interleukin-6; Male; Matrix Metalloproteinases; Neoplastic Stem Cells; Prostatic Neoplasms; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction | 2012 |
Bad neighbors: arsenic-induced tumor cells convert normal stem cells into a cancerous phenotype.
Topics: Arsenic; Cell Transformation, Neoplastic; Epithelial Cells; Gene Expression Regulation, Neoplastic; Humans; Male; Neoplastic Stem Cells; Prostatic Neoplasms | 2012 |
Agglomerates of aberrant DNA methylation are associated with toxicant-induced malignant transformation.
Topics: Animals; Arsenic; Cadherins; Carcinoma; Cell Line, Tumor; Cell Transformation, Neoplastic; DNA Methylation; DNA, Neoplasm; Epigenesis, Genetic; Female; Genes, Homeobox; Histones; Humans; Lysine; Male; Mice; Mice, Nude; Multigene Family; Neoplasm Transplantation; Prostatic Neoplasms; Protein Processing, Post-Translational | 2012 |
Acquisition of androgen independence by human prostate epithelial cells during arsenic-induced malignant transformation.
Topics: Androgen Antagonists; Androgens; Animals; Arsenic; Cell Line; Cell Proliferation; Cell Transformation, Neoplastic; Dihydrotestosterone; Epidermal Growth Factor; Epithelial Cells; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Flutamide; Gene Expression Regulation; Humans; Male; Mice; Pituitary Gland; Prostate; Prostatic Neoplasms; Receptors, Androgen; RNA, Messenger | 2005 |
Enhanced expression of metallothionein isoform 3 protein in tumor heterotransplants derived from As+3- and Cd+2-transformed human urothelial cells.
Topics: Animals; Arsenic; Biomarkers, Tumor; Breast Neoplasms; Cadmium; Cell Transformation, Neoplastic; Cells, Cultured; Female; Humans; Immunohistochemistry; Male; Metallothionein; Metallothionein 3; Mice; Neoplasm Transplantation; Prostatic Neoplasms; Protein Isoforms; RNA, Messenger; Transplantation, Heterologous; Urinary Bladder Neoplasms | 2006 |
Mechanisms of acquired androgen independence during arsenic-induced malignant transformation of human prostate epithelial cells.
Topics: Androgens; Arsenic; Blotting, Western; Cell Proliferation; Cell Transformation, Neoplastic; Cells, Cultured; Environmental Pollutants; Epithelial Cells; Humans; Male; MAP Kinase Signaling System; Models, Biological; Prostate; Prostatic Neoplasms; Proto-Oncogene Proteins p21(ras); raf Kinases; Receptor, ErbB-2; Receptors, Androgen; Reverse Transcriptase Polymerase Chain Reaction | 2007 |
Vascular imaging of solid tumors in rats with a radioactive arsenic-labeled antibody that binds exposed phosphatidylserine.
Topics: Animals; Antibodies, Monoclonal; Arsenic; Endothelium, Vascular; Male; Neovascularization, Pathologic; Phosphatidylserines; Positron-Emission Tomography; Prostatic Neoplasms; Radioimmunodetection; Radioisotopes; Rats; Tissue Distribution; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2008 |